Navigation Links
Stem Cell Markets - New Market Report
Date:11/5/2013

erapies 117
9.1.1 Cells as Immunotherapies 119
9.1.2 Tissue Engineering 119
9.1.3 Small Molecules and Biologics 120
9.1.4 Stem Cells for Drug Discovery and Toxicity Testing 121
9.2 Cell and Tissue Banking 121
9.3 Industry Parameters for Tissue Engineering and Stem Cell Companies 123
9.3.1 Commercial Products and Services in Tissue Engineering and Stem Cell Sector 123
9.3.2 Breakdown of TE and Stem Cell Industry Spending by Segment 124
9.3.3 Spending in the TE and Stem Cell Sector by Developmental Stage 127
9.3.4 Number of Companies at Each Stage of Development 127
9.3.5 Geographical Distribution of Spending for TE and Stem Industry 128
9.4 Stem Cell Use in the U.S. 129
9.4.1 Autologous Stem Cell Use in the U.S. 129
9.4.2 Limbal Stem Cells 129
9.4.3 Bone Marrow Stem Cells 130
9.4.4 Adipose Tissue Stem Cells 130
9.4.5 Allograft Stem Cell Use in the U.S. 130
9.5 Cell Therapy and Regenerative Medicine Companies in Europe 131
9.5.1 European Cell Therapy Product Approach 132
9.5.2 Autologous vs. Allogeneic Firms in Europe 133
9.5.3 Cell Therapies in Europe by Country 133
9.5.4 European Stem Cell Platforms by Cell Source 134
9.5.5 Stem Cell Therapy by Type in Europe 135

10. Stem Cell Therapy Industry: Market Analysis 137

10.1 Economic Benefits of Cell Therapies and Regenerative Medicines 138
10.2 Cell Therapy Industry and Capital Formation 139
10.3 Cell Therapy Market Size and Value 140
10.4 Structure of CTI 141
10.5 CTI’s Complementarities to Pharma, Biotech and Medical Device Industry 142
10.6 Exploration to Exploitation of Cell Therapy 142
10.7 Market Capitalization of Stem Cell Companies 142
10.8 Global Market for Stem Cells 143
10.8.1 U.S. Market for Stem Cells 144
10.8.2 Stem Cell Market in Europe 145
10.9 Cord Blood Banking
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
2. Geosynthetics Market (Geotextile, Geomembrane, Geogrid, Geofoam, Geonet) Volume Worth 5.6 Billion Meter Square by 2018 - New Report by MarketsandMarkets
3. Customer Experience Management Market (Network Types, Touch Points, Verticals) Worth $6.61 Billion by 2017 - New Report by MarketsandMarkets
4. Bring-Your-Own-Device Market (Mobile Device Management, Mobile Application Management) Worth $181.39 Billion by 2017 - New Report by MarketsandMarkets
5. Pressure Sensor Market (Piezoresistive, Capacitive, Electromagnetic, Resonant Solid State, Optical) Worth $7.34 Billion by 2017 - New Report by MarketsandMarkets
6. Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
7. Biofuels (Bioethanol & Biodiesel) Production in Top and Emerging Countries will be 150,975 Million Liters in 2016 - New Report by MarketsandMarkets
8. Acoustic Wave Sensor Market (SAW And BAW) Worth $721.13 Million - Global Forecast by 2018 - New Report by MarketsandMarkets
9. Cloud Radio Access Network (CLOUD RAN) Market (Components and Services) worth $11.31 Billion by 2018 - New Report by MarketsandMarkets
10. Infection Control Market (Sterilization and Disinfection) Worth $14.0 Billion by 2017- New Report by MarketsandMarkets
11. Aqua Feed Market (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Feed Acidifiers) Worth $106 Billion By 2018 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... cancers, especially leukemia, have improved greatly in the ... seem to face many health,and lifestyle challenges as ... and treatment methods, many continue to struggle with ... of life, according to a,study prepublished online in ...
... March 31 Hillenbrand,Industries, Inc. (NYSE: HB ) ... previously announced cash tender offer to purchase any,and all ... (CUSIP No.,431573AD6). The tender offer was made pursuant to ... to Purchase") and the related Letter of,Transmittal, which set ...
... 31 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... under which it may sell up to $50,million of ... a,24-month period. Alexza is not obligated to utilize any ... into and consummate other equity and,debt financing transactions., ...
... a Solid Foundation for Marriage and Family, ... offering an innovative program, "Supporting Healthy Marriage" to ... The purpose,of the program, administered by University Behavioral ... build a solid foundation,for marriage and family through ...
... to Consulting Addresses Fears That Lawyers Have That, ... Accurately Describes The Business, WASHINGTON, March 31 ... announced it is,becoming the first in the nation ... attorney. It had previously been the first in ...
... reduce lead dust during renovations , , MONDAY, March ... issued new rules designed to protect children from ... to homes and buildings. , Starting in ... standards" that are designed to reduce potential exposure ...
Cached Medicine News:Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 2Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 3Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 4Health News:Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 2Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 4Health News:'Supporting Healthy Marriage' Program Offered by Montefiore 2Health News:Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney 2Health News:New Rule Seeks to Protect Kids From Lead Paint 2
(Date:12/17/2014)... Revenue and earnings above the previous ... development In the past 2013/14 fiscal year (ended ... to EUR 4.287 billion (last year: EUR 4.190 billion) despite ... EUR 360 million. "Overall, 2013/14 was a successful fiscal year ... President and CEO of Carl Zeiss AG. "Thanks to our ...
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, Inc. ... music products, today announced that it has signed ... manufacturer and supplier of innovative prosthetic, orthotic and ... part of the agreement, RSL Steeper will promote ... specifically configured for use within UK residential care ...
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 1 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... obesity, today announced that the U.S. Food and Drug ... Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its ... is based on a substantial body of evidence gathered ...
... , IRVINE, Calif. , June 1 Cardiogenesis ... present at the Noble Financial Sixth Annual Equity Conference - ONTRACK ... Hollywood, Florida .  Executive Chairman Paul J. McCormick will ... at 5:00 pm Eastern Time ( 2:00 pm ...
Cached Medicine Technology:Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 2Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 3Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010 2
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
250L...
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Medicine Products: